Incyte Falls After Hiked 2025 Outlook Misses Wall Street's Bullish Views

ANALYSIS: Are Prediction Markets Turning Brokers Into Bookies? Incyte (INCY) stock fell on Tuesday after the biotech company reported adjusted earnings of $2.26 per share on $1.37 billion in third-quarter sales. Analysts polled by FactSet expected Incyte to earn $1.58 a share and report $1.25 billion in sales. During the year-earlier period, the company earned $1.07 per share on $1.14 billion in sales. In premarket trades on today's stock market, Incyte stock edged down 1.7% to 91.50. More to follow. Follo ...